InsiderClue
Insiders · Profile

BELVIN MARCIA

SVP, Chief Scientific Officer at CytomX Therapeutics. Filing since 22 Sep 2023. CIK 0001970752

Company
Date
Role
Action
Shares
Amount
Of holding
CTMX CytomX Therapeutics, Inc.
17 Mar 2026
SVP, Chief Scientific Officer
Sold at will
31,492
$202.27K
9.5%
CTMX CytomX Therapeutics, Inc.
16 Jun 2025
SVP, Chief Scientific Officer
Sold at will
13,884
$37.33K
4.9%
CTMX CytomX Therapeutics, Inc.
18 Mar 2025
SVP, Chief Scientific Officer
Sold at will
19,512
$11.69K
7.3%
CTMX CytomX Therapeutics, Inc.
20 Aug 2024
SVP, Chief Scientific Officer
Sold at will
4,181
$5.14K
2.3%
CTMX CytomX Therapeutics, Inc.
19 Mar 2024
SVP, Chief Scientific Officer
Sold at will
12,795
$26.68K
7.1%
CTMX CytomX Therapeutics, Inc.
20 Dec 2023
SVP, Chief Scientific Officer
Sold at will
4,077
$5.63K
2.6%
CTMX CytomX Therapeutics, Inc.
22 Sep 2023
SVP, Chief Scientific Officer
Sold at will
4,119
$5.36K
2.7%
7 decisions on file.